PUNCTUAL TRADING LIMITED

Regd. Off.: 411, Floor-4, Plot-207, Embassy Centre, Jamnalal Bajaj Marg, Nariman Point, Mumbai - 400 021 Tel. No. : 022-61155300 Email add : [email protected] CIN: L67120MH1986PLC039919

30t October 2024

To, The Secretary, BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai- 400001 Company Scrip Code: 512461

Dear Sir/Madam,

Sub: Newspaper publication of Un-Audited Standalone Financial Results.

Ref: Regulation 47 and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Please find enclosed herewith copies of Newspaper cuttings of The Free Press Journal (English) and Navshakti- (Marathi) of Wednesday, October 30, 2024 for publication of Un-Audited Standalone Financial Results of the Company for the quarter and half year ended on September 30, 2024.

Kindly acknowledge the receipt.

Thanking You,

Yours faithfully, For Punctual Trading Limited

" —— Bl TRADy (s STTNG) N2 Alcash Sukhdev Swn{ e | =1 Chief Financial Offi¢ér S _ - - X s 03, AN

%\2UGHURIWKH%RDUG IRU*DUZDUH0DULQH,QGXVWULHV/LPLWHG

6G 69\$WUH ([HFXWLYH'LUHFWRU

3ODFH0XPEDL

127(6

7KHILQDQFLDOUHVXOWVKDYHEHHQUHYLHZHGE\$XGLW&RPPLWWHHDQGDSSURYHGE\WKH%RDUGRI'LUHFWRUVDWLWVPHHWLQJKHOG RQ2FWREHU7KH\$XGLWRUVRIWKH&RPSDQ\KDYHFDUULHGRXWOLPLWHGUHYLHZRIWKHXQDXGLWHGILQDQFLDOUHVXOWVIRU WKHTXDUWHUDQGKDOI\HDUHQGHG6HSWHPEHU

&RPSDUDWLYHILQDQFLDOVLQIRUPDWLRQRIWKHSUHYLRXVTXDUWHUKDYHEHHQUHJURXSHGDQGUHFODVVLILHGZKHUHYHUQHFHVVDU\ WRFRUUHVSRQGWRWKHILJXUHVRIWKHFXUUHQWTXDUWHU

7KHDERYHLVDQH[WUDFWRIWKHGHWDLOHGIRUPDWRI4XDUWHUO)LQDQFLDO5HVXOWVILOHGZLWKWKH6WRFN([FKDQJHVXQGHU 5HJXODWLRQRIWKH6(%,/LVWLQJ2EOLJDWLRQVDQG2WKHU'LVFORVXUH5HTXLUHPHQWV?5HJXODWLRQV7KHIXOOIRUPDWRI WKH4XDUWHUO)LQDQFLDO5HVXOWVDUHDYDLODEOHRQWKH6WRFN([FKDQJHZHEVLWHVZZZEVHLQGLDFRP?DQGWKH&RPSDQ\ ZHEVLWHZZZJDUZDUHPDULQHFRP

V

5HJG2IILFHUG)ORRU3URVSHFW&KDPEHUV'15RDG)RUW0XPEDL &,1/0+3/&

imprisonment and/or penalty as provided under the Act.

Place : Mumbai Date : 30.10.2024 Sd/- Authorised Ocer For Centrum Housing Finance Ltd

'amR>r 'ZmMmAmdmO

www.navshakti.co.in

BID/OFFER PERIOD ANCHOR INVESTOR BIDDING DATE OPENED AND CLOSED ON : TUESDAY, OCTOBER 22, 2024 BID/OFFER OPENED ON : WEDNESDAY, OCTOBER 23, 2024 BID/ OFFER CLOSED ON : FRIDAY, OCTOBER 25, 2024

The Offer was made in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended (the "SCRR"), read with Regulation 31 of the SEBI ICDR Regulations. The Offer was made through the Book Building Process in accordance with Regulation 6(1) of the SEBI ICDR Regulations wherein not more than 50% of the Offer was available for allocation on a proportionate basis to Qualified Institutional Buyers ("QIBS") (the "QIB Portion"), provided that our Company in consultation with the BRLMs, allocated up to 60% of the QIB Portion to Anchor
Investors on a discretionary basis in accordance with SEBI ICDR Regulations (t for domestic Mutual Funds, subject to valid Bids received from the domestic Mutual Funds at or above the price at which allocation was made to Anchor Investors ("Anchor Investor Allocation Price"). In the event of under-subscription or non-allocation in the Anchor Investor Portion, the balance Equity Shares could have been added to the QIB Portion (other than the Anchor Investor Portion) (the "Net QIB Portion"). Further, 5% of the Net QIB Portion was made available for allocation on a proportionate basis to Mutual Funds only, subject to valid Bids received at or above the Offer Price, and the remainder of the Net QIB Portion was available for allocation on a proportionate basis to all QIBs, including Mutual Funds, subject to valid Bids received at or above the Offer Price. However, if the aggregate demand from Mutual Funds was less than 5% of the Net QIB Portion, the balance Equity Shares available for allocation in the Mutual Fund Portion could have been added to the remaining Net OIB Portion for proportionate allocation to all QIBs. Further, not less than 15% of the Offer was available for allocation to Non-Institutional Investors ("Non-Institutional Portion") of which one-third of the Non-Institutional Portion was available for allocation to Bidders with an application size of more than ₹0.20 million and up to ₹1.00 million and two-thirds of the Non-Institutional Portion was available for allocation to Bidders with an application size of more than ₹1.00 million and under-subscription in either of these two sub-categories of the Non-Institutional Portion could have been allocated to Bidders in the other sub-category of the Non-Institutional Portion in accordance with the SEBI ICDR Regulations, subject to valid Bids received at or above the Offer Price. Further, not less than 35% of the Offer was available for allocation to Retail Individual Portion ("Retail Portion"), in accordance with the SEBI ICDR Regulations, subject to valid Bids received from them at or above the Offer Price. All Bidders (except Anchor Investors) were mandatorily required to participate in this Offer only through the Application Supported by Blocked Amount ("ASBA") process and provide details of their respective bank account (including UPI ID (defined hereinafter) in case of UPI Bidders (defined hereinafter) in which the Bid Amount was blocked by the SCSBs or by the Sponsor Banks und not permitted to participate in the Anchor Investor Portion through the ASBA process. For details, see "Offer Procedure" on page 412 of the Prospectus.

The bidding for Anchor Investor opened and closed on Tuesday, October 22, 2024. The company received 19 applications from 15 anchor investors for 52,68,438 equity shares. The Anchor investor price was finalized at ₹ 352 per Equity Share. A total of 4,727,980 shares were allocated under the Anchor Investor Portion aggregating to ₹1,664,248,960.00/-

The Offer received 178,742 applications for 25,878,846 Equity Shares (before rejections) resulting in 1.64 times subscription. The details of the applications received in the Offer from various categories are as under: (before rejections)

Final Demand

final demand as per BSE and NSE as on the Bid/Offer Closing Date and as at different Bid prices is as under

C. Allotment to Non-Institutional Investors (more than₹1.00 million) (After Rejections) (including ASBA Applications)

The Basis of Allotment to the Non-Institutional Investors (more than ₹1.00 million), who have bid at the Offer Price of ₹352 per Equity Share or above, was finalized in consultation with the BSE. This category has been subscribed to the extent of 0.51 times. The total number of Equity Shares Allotted in this category is 808,584 Equity Shares to 219 successful Non-Institutional Investors (more than ₹1.00 million). The categorywise details of the Basis of Allotment are as under:

The Basis of Allotment was finalized in consultation with the Designated Stock Exchange, being the BSE, on October 28, 2024.

A. Allotment to Retail Individual Investors (after rejections) (including ASBA Applications)

The Basis of Allotment to the Retail Individual Investors, who have bid at the Cut-Off Price or at the Offer Price of ₹352 per Equity Share, was finalized in consultation with the BSE. This category has been subscribed to the extent of 1.65 times. The total number of Equity Shares Allotted in the Retail Portion is 5,625,736 Equity Shares to 133,946 successful Retail Individual Investors. This includes spillover of 109,758 shares from NII 2 category. The category-wise details of the Basis of Allotment are as under:

B. Allotment to Non-Institutional Investors (more than ₹0.20 million and up to ₹1.00 million) (After Reiections) (including ASBA Applications) The Basis of Allotment to the Non-Institutional Investors (more than ₹0.20 million and up to ₹1.00 million), who have bid at the Offer Price of ₹352 per Equity Share or above, was finalized in consultation with the BSE. This category has been subscribed to the extent of 0.83 times. The total number of Equity Shares Allotted in this category is 1,288,854 Equity Shares to 1,952 successful Non-Institutional Investors (more than ₹0.20 million and up to ₹1.00 million). This includes spillover of 500,857 shares from NII 2 category. The category-wise details of the Basis of Allotment are as under

D. Allotment to QIBs (excluding Anchor Investors) (After Rejections)

Allotment to QIBs, who have Bid at the Offer Price of ₹ 352 per Equity Share or above, has been done on a proportionate basis in consultation with the BSE. This category has been subscribed to the extent of 2.75 times of Net QIB Portion. As per the SEBI Requlations. Mutual Funds were Allotted 5% of the Equity Shares of Net QIB Portion available i.e. 165,440 Equity Shares and other QIBs and unsatisfied demand of Mutual Funds were Allotted the remaining available Equity Shares i.e. 3,143,343 Equity Shares on a proportionate basis. The total number of
Equity Shares Allotted in the QIB Portion is 3,308,783 Equity Shares, which were a Explorer of 7,840 shares from NII 2 category to Mutual Fund category and 148,955 shares to other QIBs and unsatisfied demand of Mutual
Funds. The category-wise details of the Basis of Allotment are as under:

E. Allotment to Anchor Investors (After Rejections)

The Company, in consultation with the BRLMs, have allocated 4,727,980 Equity Shares to 15 Anchor Investors (through 19 Applications) at the Anchor Investor Issue Price of ₹352 per Equity Share in accordance with the SEBI

The IPO Committee of our Company on Monday, October 28, 2024 has taken on record the Basis of Allotment of Equity Shares approved by the Designated Stock Exchange, being BSE and has allotted the Equity Shares to various successful Bidders. The Allotment Advice-cum-
Intimations and/ or notices will be dispatched to the address of the investors as registe Self Certified Syndicate Banks for unblocking of funds, transfer to Public Offer Account have been issued on October 28, 2024 and payment to non-Syndicate brokers have been issued on October 29, 2024. In case the same is not received within ten days, investors may contact the Registrar to the Offer at the address given below. The Equity Shares Allotted to the successful Allottees have been uploaded on October 29, 2024 for credit into the respective beneficiary accounts subject to validation of the account details with the depositories concerned. The Company has filed the Listing application with BSE and NSE on October 29, 2024. The Company has received listing and trading approval from BSE and NSE and the trading will commence on Wednesday October 30, 2024.

Note: All capitalised terms used and not specifically defined herein shall have the same meaning as ascribed to them in the Prospectus

INVESTORS PLEASE NOTE

The details of the Allotment made will be hosted on the website of the Registrar to the Offer, Link Intime India Private Limited at www.linkintime.co.in

All future correspondence in this regard may kindly be addressed to the Registrar to the Offer quoting full name of the first/ sole Bidder, Bid
cum Application Form number, Bidder DP ID, Client ID, PAN, date of submission Equity Shares applied for, the name and address of the Designated Intermediary where the Bid cum Application Form was submitted by the Bidder and a copy of the Acknowledgment Slip received from the Designated Intermediary at the address given below:

Place: Mumbai

Date: October 29, 2024

Link Intime India Private Limited

C 101, 1st Floor, 247 Park, L.B.S Marg, Vikhroli West, Mumbai - 400 083, Maharashtra Telephone no.: +91 810 811 4949 Email: [email protected] Investor grievance email: [email protected] Website: www.linkintime.co.in Contact person: Shanti Gopalkrishnar SEBI Registration Number: INR000004058

For GODAVARI BIOREFINERIES LIMITED On behalf of the Board of Directors $Sd$ Manoj Jain Company Secretary and Compliance Officer

THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF GODAVARI BIOREFINERIES LIMITED.

GODAVARI BIOREFINERIES LIMITED has filed the Prospectus dated October 25, 2024 with RoC. The Prospectus is available on the website of SEBI at www.sebi.gov.in, websites of the Stock Exchanges i.e. BSE and NSE at www.bseindia.com and www.nseindia.com, respectively, on the website of the Company at www.godavaribiorefineries.com and the websites of the BRLMs i.e. Equirus Capital Private Limited and SBI Capital Markets Limited at www.equirus.com and www.sbicaps.com, respectively. Investors should note that investment in equity shares involves a high degree of risk and for details relating to such risk, please see the section entitled "Risk Factors" on page 32 of the Prospectus. Potential investors should not rely on the Draft Red Herring Prospectus filed with SEBI for making any investment decisions and
instead should place reliance on the Red Herring Prospectus and Prospectus.

The Equity Shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended ("U.S. Securities Act") or any state securities laws in the United States, and unless so registered, and may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requ securities laws. Accordingly, the Equity Shares are being offered and sold only outside the United States in "offshore transactions" as defined
in and in compliance with Regulation S under the U.S. Securities Act and the a are made